Informazione:
Errore:
ID
24369
Descrizione
Study part: Study Conclusion End of Study.An Open-Label Extension phase 3 Study with REQUIP (ropinirole) CR for Subjects from Studies 101468/165, 101468/168 and 101468/169 Patient Level Data. Study ID:101468/248, Clinical Study ID: 101468/248.
Keywords
versioni (1)
- 30/07/17 30/07/17 -
Titolare del copyright
GlaxoSmithKline
Caricato su
30 luglio 2017
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC 3.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Study Conclusion End of Study Ropinirole NCT00632736
Study Conclusion End of Study
- StudyEvent: ODM
Similar models
Study Conclusion End of Study
- StudyEvent: ODM
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Subject ID
Item
Subject ID
text
C2348585 (UMLS CUI [1])
Date of subject completion or withdrawal
Item
Date of subject completion or withdrawal
date
C2983670 (UMLS CUI [1])
Study Subject Participation Status
Item
Was the subject withdrawn from the study?
boolean
C2348568 (UMLS CUI [1])
Item
The primary reason for withdrawal:
text
C0392360 (UMLS CUI [1,1])
C1707478 (UMLS CUI [1,2])
C0008972 (UMLS CUI [1,3])
C1707478 (UMLS CUI [1,2])
C0008972 (UMLS CUI [1,3])
CL Item
Adverse event (record details on the Non-Serious Adverse Event or Serious Adverse Event pages as appropriate) (Adverse event (record details on the Non-Serious Adverse Event or Serious Adverse Event pages as appropriate))
C0877248 (UMLS CUI-1)
CL Item
Lost to follow-up (Lost to follow-up)
C1302313 (UMLS CUI-1)
CL Item
Protocol violation (Protocol violation)
C1709750 (UMLS CUI-1)
CL Item
Subject decided to withdraw from the study (Subject decided to withdraw from the study)
C2348571 (UMLS CUI-1)
CL Item
Lack of efficacy (Lack of efficacy)
C0235828 (UMLS CUI-1)
CL Item
Sponsor terminated study (Sponsor terminated study)
C1710224 (UMLS CUI-1)
CL Item
Disease progression (Disease progression)
C0242656 (UMLS CUI-1)
CL Item
Other, specify (Other, specify)
C0205394 (UMLS CUI-1)
Other
Item
If other, please specify
text
C0205394 (UMLS CUI [1])
CL Item
Yes (Yes)
CL Item
No (No)
CL Item
Not Applicable (not of childbearing potential or male) (Not Applicable (not of childbearing potential or male))